Intuitive Surgical, Inc. (ISRG)
521.15 USD +47.42 (+10.01%) Volume: 4.06M
Intuitive Surgical, Inc.’s stock price soars to $521.15, marking a significant trading session increase of +10.01% with a robust trading volume of 4.06M. The company’s stock has shown a remarkable year-to-date percentage change of +54.48%, underlining its strong market performance.
Latest developments on Intuitive Surgical, Inc.
Intuitive Surgical, Inc. (ISRG) has been making waves in the stock market recently, with a series of key events leading up to today’s stock price movements. The company beat Q3 earnings and revenue estimates, showcasing strong financial performance. Additionally, the announcement of an executive leaving for Occam Labs, an incubator for surgical robotics startup Capstan Medical, added to the buzz surrounding Intuitive Surgical. The stock surged 10% amid high demand for the da Vinci 5 system, with a full rollout scheduled for 2025. Analysts have raised their forecasts on the uptake of the DV5 system, contributing to the positive sentiment surrounding Intuitive Surgical’s stock. With double-digit growth in Q3 revenue and earnings, the company’s financial growth fueled by AI-driven Da Vinci systems has impressed investors and analysts alike.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
π‘ Before itβs here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- β Unlimited Research Summaries
- β Personalised Alerts
- β Custom Watchlists
- β Company Analytics and News
- β Events & Webinars
